Association between SGLT2 Inhibitors and Cardiac Rehabilitation Outcomes in Patients with Cardiovascular Disease and Type 2 Diabetes Mellitus.

MLA

Kashima, Ayuko, et al. “Association between SGLT2 Inhibitors and Cardiac Rehabilitation Outcomes in Patients with Cardiovascular Disease and Type 2 Diabetes Mellitus.” Journal of Clinical Medicine, vol. 11, no. 19, Oct. 2022. EBSCOhost, https://doi.org/10.3390/jcm11195956.

APA

Kashima, A., Kamiya, K., Hamazaki, N., Ueno, K., Nozaki, K., Ichikawa, T., Yamashita, M., Uchida, S., Noda, T., Hotta, K., Maekawa, E., Yamaoka-Tojo, M., Matsunaga, A., & Ako, J. (2022). Association between SGLT2 Inhibitors and Cardiac Rehabilitation Outcomes in Patients with Cardiovascular Disease and Type 2 Diabetes Mellitus. Journal of Clinical Medicine, 11(19). https://doi.org/10.3390/jcm11195956

Chicago

Kashima, Ayuko, Kentaro Kamiya, Nobuaki Hamazaki, Kensuke Ueno, Kohei Nozaki, Takafumi Ichikawa, Masashi Yamashita, et al. 2022. “Association between SGLT2 Inhibitors and Cardiac Rehabilitation Outcomes in Patients with Cardiovascular Disease and Type 2 Diabetes Mellitus.” Journal of Clinical Medicine 11 (19). doi:10.3390/jcm11195956.